Marie Balsat

1.3k total citations
41 papers, 332 citations indexed

About

Marie Balsat is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Oncology. According to data from OpenAlex, Marie Balsat has authored 41 papers receiving a total of 332 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Hematology, 16 papers in Public Health, Environmental and Occupational Health and 11 papers in Oncology. Recurrent topics in Marie Balsat's work include Acute Lymphoblastic Leukemia research (15 papers), Hematopoietic Stem Cell Transplantation (12 papers) and Acute Myeloid Leukemia Research (9 papers). Marie Balsat is often cited by papers focused on Acute Lymphoblastic Leukemia research (15 papers), Hematopoietic Stem Cell Transplantation (12 papers) and Acute Myeloid Leukemia Research (9 papers). Marie Balsat collaborates with scholars based in France, United States and Belgium. Marie Balsat's co-authors include Gilles Salles, Nicolas Boissel, Fiorenza Barraco, Patrice Chevallier, Hervé Dombret, Xavier Thomas, Sophie Ducastelle-Leprêtre, Gaëlle Fossard, Emmanuel Raffoux and Sandrine Hayette and has published in prestigious journals such as Blood, Clinical Cancer Research and Journal of Clinical Microbiology.

In The Last Decade

Marie Balsat

36 papers receiving 327 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marie Balsat France	11	171	121	103	46	39	41	332
Revathi Raj India	10	132 0.8×	62 0.5×	77 0.7×	43 0.9×	51 1.3×	74	329
Prassede Salutari Italy	13	220 1.3×	94 0.8×	132 1.3×	25 0.5×	63 1.6×	40	438
Vasiliki Vlacha Greece	8	104 0.6×	63 0.5×	37 0.4×	20 0.4×	33 0.8×	16	286
Ulrik Malthe Overgaard Denmark	9	133 0.8×	104 0.9×	41 0.4×	51 1.1×	43 1.1×	33	309
Fahad Almohareb Saudi Arabia	10	181 1.1×	116 1.0×	69 0.7×	20 0.4×	80 2.1×	41	404
Ramya Uppuluri India	10	119 0.7×	44 0.4×	62 0.6×	39 0.8×	49 1.3×	61	267
L. S. Zubarovskaya Russia	9	126 0.7×	50 0.4×	62 0.6×	18 0.4×	34 0.9×	140	297
Irene García‐Cadenas Spain	11	270 1.6×	60 0.5×	198 1.9×	23 0.5×	57 1.5×	45	407
Smeeta Gajendra India	10	88 0.5×	52 0.4×	54 0.5×	21 0.5×	64 1.6×	52	261
Zeinab Afify United States	9	82 0.5×	82 0.7×	32 0.3×	76 1.7×	40 1.0×	28	338

Countries citing papers authored by Marie Balsat

Since Specialization

Citations

This map shows the geographic impact of Marie Balsat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marie Balsat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marie Balsat more than expected).

Fields of papers citing papers by Marie Balsat

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marie Balsat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marie Balsat. The network helps show where Marie Balsat may publish in the future.

Co-authorship network of co-authors of Marie Balsat

This figure shows the co-authorship network connecting the top 25 collaborators of Marie Balsat. A scholar is included among the top collaborators of Marie Balsat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marie Balsat. Marie Balsat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dubois, Valérie, Marie Balsat, Sophie Ducastelle, et al.. (2025). HLA diversity is associated with TKI response and treatment‐free remission in chronic myeloid leukemia. HemaSphere. 9(11). e70261–e70261.

Balsat, Marie, Hélène Labussière‐Wallet, Vincent Alcazer, et al.. (2025). Thrombocytosis drives alteration of primary hemostasis and acquired von willebrand syndrome occurrence in myeloproliferative neoplasms. Blood. 146(Supplement 1). 5570–5570.

Mouton, William, Vincent Alcazer, Caroline Duprè, et al.. (2025). Temporal Evolution of Functional Immune Reconstitution after Allogeneic HSCT. Transplantation and Cellular Therapy. 31(6). 367–381.

Frieri, Camilla, et al.. (2024). The role of allogeneic stem cell transplantation in severe erythropoietic protoporphyria in adults and young adults: timing and modalities. Hematology Transfusion and Cell Therapy. 46. S294–S298. 1 indexed citations

Cabannes‐Hamy, Aurélie, Guillaume P. Andrieu, Agata Cieślak, et al.. (2023). PHF6 -altered T-ALL Harbor Epigenetic Repressive Switch at Bivalent Promoters and Respond to 5-Azacitidine and Venetoclax. Clinical Cancer Research. 30(1). 94–105. 3 indexed citations

Mouton, William, Anne Conrad, Vincent Alcazer, et al.. (2022). Distinct Immune Reconstitution Profiles Captured by Immune Functional Assays at 6 Months Post Allogeneic Hematopoietic Stem Cell Transplantation. Transplantation and Cellular Therapy. 29(2). 94.e1–94.e13. 5 indexed citations

Pleșa, Adriana, Gaëlle Fossard, Fiorenza Barraco, et al.. (2022). Impact on Outcome of Minimal Residual Disease after Hematopoietic Stem Cell Transplantation with Fludarabine, Amsacrine, and Cytosine Arabinoside-Busulfan Conditioning: A Retrospective Monocentric Study. Transplantation and Cellular Therapy. 29(1). 38.e1–38.e9. 4 indexed citations

Saison, Carole, Virginie Mathias, Marie Balsat, et al.. (2022). Long-Term Persistence of Mixed Full Donor Chimerism after Double Cord Blood Transplantation. Example of Tolerance in Allogeneic Hematopoietic Cell Transplantation Setting. Blood. 140(Supplement 1). 12861–12862.

Cabannes‐Hamy, Aurélie, Éolia Brissot, Thibaut Leguay, et al.. (2022). High tumor burden before blinatumomab has a negative impact on the outcome of adult patients with B-cell precursor acute lymphoblastic leukemia. A real-world study by the GRAALL. Haematologica. 107(9). 2072–2080. 24 indexed citations

10.

Chevallier, Patrice, Rathana Kim, Marc Delord, et al.. (2022). Fractionated Inotuzumab Ozogamicin Combined with Low-Intensity Chemotherapy in Older Patients with Newly Diagnosed CD22+ Philadelphia Chromosome (Ph)-Negative B-Cell Precursor (BCP) Acute Lymphoblastic Leukemia (ALL): Results of the EWALL-INO Study. Blood. 140(Supplement 1). 6114–6116. 22 indexed citations

11.

Chevallier, Patrice, Michael Doubek, Françoise Huguet, et al.. (2021). Fractionated Inotuzumab Ozogamicin Combined with Low-Intensity Chemotherapy Provides Very Good Outcome in Older Patients with Newly Diagnosed CD22+ Philadelphia Chromosome-Negative B-Cell Precursor Acute Lymphoblastic Leukemia: First Results from the EWALL-INO Study. Blood. 138(Supplement 1). 511–511. 10 indexed citations

12.

Hayette, Sandrine, Maxime Vallée, Claire Bardel, et al.. (2021). Performances of Targeted RNA Sequencing for the Analysis of Fusion Transcripts, Gene Mutation, and Expression in Hematological Malignancies. HemaSphere. 5(2). e522–e522. 5 indexed citations

13.

Thomas, Xavier, Gaëlle Fossard, Mohamed Elhamri, et al.. (2020). LYON-UNIVERSITY HOSPITAL EXPERIENCE WITH GEMTUZUMAB OZOGAMICIN THERAPY IN ACUTE MYELOID LEUKEMIA: A ‘REAL-LIFE’ STUDY. Mediterranean Journal of Hematology and Infectious Diseases. 12(1). e2020020–e2020020. 2 indexed citations

14.

Orvain, Corentin, Marie Balsat, Emmanuelle Tavernier, et al.. (2020). Thromboembolism Prophylaxis in Adult Patients with Acute Lymphoblastic Leukemia Treated in the GRAALL-2005 Study. Blood. 136(3). 328–338. 30 indexed citations

15.

Schmidt, Aline, Éolia Brissot, Marie Balsat, et al.. (2019). The Combination of Venetoclax and Tofacitinib Induced Hematological Responses in Patients with Relapse/ Refractory T-ALL with BCL2 Expression and Surface IL7R Expression or IL7R-Pathway Mutations (On behalf of the GRAALL). Blood. 134(Supplement_1). 1339–1339. 2 indexed citations

16.

Heiblig, Maël, Mohamed Elhamri, Marie Balsat, et al.. (2016). Treatment patterns and comparative effectiveness in elderly acute myeloid leukemia patients (age 70 years or older): the Lyon-university hospital experience. Leukemia & lymphoma. 58(1). 110–117. 10 indexed citations

17.

Michallet, Mauricette, Mohamad Sobh, Fiorenza Barraco, et al.. (2016). Addition of More Immunosuppressive Drugs As Graft-Versus-Host Disease (GVHD) Prophylaxis Does Not Improve Gvhd Outcomes in Reduced Intensity Allogeneic Hematopoietic Cell Transplantation from Unrelated Donors. Blood. 128(22). 5786–5786. 1 indexed citations

18.

Lengliné, Étienne, Bernard Drénou, Pierre Péterlin, et al.. (2016). Nationwide Survey on the Use of Eltrombopag in Patients with Severe Aplastic Anemia: Report on Behalf of the French Reference Center for Aplastic Anemia. Blood. 128(22). 2684–2684. 10 indexed citations

19.

Balsat, Marie, Aliénor Xhaard, Étienne Lengliné, et al.. (2015). Worsening of Respiratory Status during Neutropenia Recovery in Noncritically Ill Hematological Patients: Results of a Prospective Multicenter Study. Respiration. 90(3). 229–234. 6 indexed citations

20.

Balsat, Marie & Jérôme Cornillon. (2013). Actualités moléculaires et thérapeutiques dans la Leucémie à Tricholeucocytes. Bulletin du Cancer. 100(10). 1043–1047. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact